Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.440 | 1.580 | 0.140 |
Shares | 98.570 | 98.570 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.424 | 14.494 |
Price to Book | 2.816 | 2.165 |
Price to Sales | 1.777 | 1.689 |
Price to Cash Flow | 12.816 | 12.056 |
Dividend Yield | 2.710 | 2.854 |
5 Years Earnings Growth | 7.669 | 8.907 |
Name | Net % | Category Average |
---|---|---|
Industrials | 56.860 | 39.794 |
Financial Services | 15.120 | 21.375 |
Technology | 8.070 | 8.426 |
Consumer Defensive | 7.590 | 4.563 |
Consumer Cyclical | 6.650 | 6.138 |
Healthcare | 5.720 | 9.585 |
Number of long holdings: 32
Number of short holdings: 8
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Volvo B | SE0000115446 | 8.75 | 269.70 | -0.66% | |
ASSA ABLOY B | SE0007100581 | 6.95 | 331.7 | -0.18% | |
SEB A | SE0000148884 | 6.47 | 150.55 | -0.20% | |
Hexagon B | SE0015961909 | 5.85 | 92.50 | -0.01% | |
Atlas Copco A | SE0017486889 | 5.61 | 173.4 | -0.46% | |
Essity B | SE0009922164 | 4.99 | 302.20 | 0.00% | |
Sandvik AB | SE0000667891 | 4.86 | 203.20 | +0.30% | |
ABB | CH0012221716 | 4.69 | 49.96 | -0.40% | |
AstraZeneca | GB0009895292 | 4.62 | 10,474.0 | 0.00% | |
Svenska Handelsbanken A | SE0007100599 | 4.43 | 110.95 | +0.14% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309707 | 130.06B | 23.23 | 13.00 | 13.05 | ||
SE0010127894 | 55.07B | 11.69 | 5.84 | - | ||
Handelsbanken Global Tema (A1 SEK) | 50.65B | 23.53 | 9.39 | 13.22 | ||
Handelsbanken Global Tema (B1 SEK) | 50.65B | 23.54 | 9.39 | - | ||
Handelsbanken Multi Asset 50 A1 S | 32.58B | 11.20 | 4.00 | 5.96 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review